Gum suppliers spur interest with intros

February 2011
Chain Drug Review;2/28/2011, Vol. 33 Issue 4, p22
Trade Publication
The article reports on the efforts of gum suppliers to maintain new products of the segment in the pharmaceutical industry in the U.S.


Related Articles

  • Gum's growing up.  // Stagnito's New Products;2007, p24 

    The article offers a look at trends in the chewing gum industry. According to the Mintel New Products Database, almost 40 percent of new product gum launches in 2006 contained xylitol, a sugar substitute known for its teeth protecting properties. A number of chewing gums contain more vitamins...

  • Get Back in the Box! Looney, William // Pharmaceutical Executive;Sep2011, Vol. 31 Issue 9, p10 

    The article presents the author's comments concerning the pharmaceutical industry of the U.S. The author calls it as the inscrutable industry, where crisis and complacency coexist peacefully. He also states that despite the pervasive gloom, most forecasts reveal the country will stay atop the...

  • Newswire.  // Brandweek;3/19/2007, Vol. 48 Issue 12, p8 

    The article presents news briefs relating to the marketing and advertising industry. Automobile maker Ford Motor Co. Is selling its Aston Martin automobiles to an investment group led by British race shop owner David Richards in a deal worth $925 million but will retain a share worth $77...

  • The patently obvious. Chase, James // Medical Marketing & Media;Dec2010, Vol. 45 Issue 12, p6 

    The article presents the author's market analysis on pharmaceutical industries in the U.S. for 2011 with a list of expirations of their corresponding brand names that worth 25 billion dollars in sales. These brand names include Lipitor from Pfizer Inc., Zyprexa from Eli Lilly & Co. and Levaquin...

  • Agenda.  // Medical Marketing & Media;Nov2009, Vol. 44 Issue 11, p6 

    The article presents updates related to drug marketing in the U.S. It cites "The Career & Salary Survey 2000" Premium Edition which offers insights on pharmaceutical marketing. It also highlights a guide for product developments across key therapeutic categoties. Furthermore, it states the...

  • One-product wonders. CHASE, JAMES // Medical Marketing & Media;May2014, Vol. 49 Issue 5, p8 

    The article presents the author's views on the condition of the pharmaceutical industry in the U.S. as of May 2014 which posted a 3.2% increase in sales that amounted to $392.2 billion in 2013. He states that the increase is attributed to the stabilization of patent cliffs and new product...

  • Industry Basics: R&D and marketing.  // Pharmaceutical Representative;Feb2009, Vol. 39 Issue 2, p24 

    The article presents an overview of pharmaceutical research and development and the marketing process in the U.S. It highlights the clinical trial process, pharmacoeconomic studies, marketing life cycle, product promotion strategies as well as major pharmaceutical distribution channels. It...

  • Bio News.  // Contract Pharma;May2012, Vol. 14 Issue 4, p36 

    The article offers news briefs related to the pharmaceutical industry in the U.S. in 2012. An agreement has been signed by Lonza and Agennix AG for the manufacture of Agennix's oral Dendritic Cell Mediated Immunotherapy (DCMI). Baxter International Inc. plans to construct a state-of-the-art...

  • A Typical Scenario: Critical Success Factors.  // Contract Pharma;Jun2013, Vol. 15 Issue 5, p102 

    The article focuses on the contract staffing model which illustrates the benefits and challenges of a pharmaceutical firms to attract more clients on-site staffing solutions in the U.S. It presents a study of a large biopharmaceutical company on its new product development strategy focusing on...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics